CSI Market
Sign In | Register

Sorrento Therapeutics Inc (SRNEQ) Annual Income Statement

Annual · GAAP · USD millions
Access SRNEQ quarterly income statements →
Reviewing income statement figures over time helps illustrate how Sorrento Therapeutics Inc generates earnings and manages operating expenses.
View historic periods: Download as CSV:
Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.
Annual Report, GAAP in USD millions
ITEM 		(Dec 31 2022)
2022 		(Dec 31 2021) (Dec 31 2020) (Dec 31 2019) (Dec 31 2018)
Revenues
Revenue From Contract With Customer Including Assessed Tax62.84
Total Revenue62.84
Costs & Expenses
Cost of Goods and Services Sold28.91
Gross Profit33.93
Selling, Administration, Marketing182.34
Depreciation & Amortization4.33
Research and Development Expense (Excluding Acquired in Process Cost)221.23
Impairment of Intangible Assets (Excluding Goodwill)124.19
Other Operating Expense / -Income-58.59
Legal Fees64.75
Total operating costs including COS567.15
Operating income / -loss-504.32
Interest Expense8.57
Net Interest (-)Expense / Income-8.57
Extinguishment of Debt27.01
Loss / -Gain on Investment-83.18
Foreign Currency Transaction Gain (Loss), before Tax0.00
Other loss / -income105.03
Total costs & expenses624.59
Income & Taxes
Income / -loss before income taxes-561.75
Income taxes expenses / -benefit2.42
Income after income taxes-577.76
Net income / -loss of other equity-13.59
Income / -loss from continuing operations-577.76
Non-controlling interests-4.91
Net income / -loss-577.76
Income / -loss to shareholder-572.84
EBIT-553.17
EBITD-539.93
EBITDA-539.93
Earnings Per Share
Basic EPS (excl. extra items)-1.37
Basic Net EPS-1.37
Basic shares outstanding (Mill. of Units)419.32
Diluted Net EPS-1.37
Diluted average shares (Mill. of Units)419.32
4 historic quarters locked

Sign in to unlock the full Sorrento Therapeutics Inc income statement history.

Sign In Create Free Account

About SRNEQ Annual Income Statement

What this statement shows

This page presents issuer-reported income statement data, detailing revenue, operating costs, expenses, and earnings as disclosed in SEC 10-K filings and standardized by CSIMarket. The income statement reflects operating performance over a reporting period rather than financial position at a single date.

Revenue and expense treatment

Revenue and expense items are aligned to support period-to-period comparability. Operating and non-operating items, interest, and income taxes are classified based on issuer disclosures and XBRL tagging.

Source & verification

  • Source: SEC 10-K filings
  • Filed with the SEC: n/a

Income statement figures represent operating results for each reporting period and may be revised in subsequent filings.